Mushrooms of the Far East hold promise for anti-cancer therapy

August 3, 2018, Far Eastern Federal University
Inonotus obliquus, Far Eastern medical mushroom. Credit: Eugenia M. Bulakh

Mushrooms from the Far East contain natural chemical compounds that could be used for the design of the novel drugs with highly specific anti-tumor activities and low toxicity. These compounds may offer new avenues for oncology, providing physicians with either standalone alternatives to chemotherapy, chemopreventive medicines, or drugs to be used in combination with other therapies.

The international team of scientists from the Far Eastern Federal University (FEFU), University of Lausanne, and the Federal Scientific Center of the East Asia Terrestrial Biodiversity FEB RAS describes the available body of research on four species with high anti- potential. The article is published in Oncotarget and contains the list of tumors, which were reported to be promising targets of the fungal compounds. Among them sarcoma, leukemia, rectum and colon cancer, stomach cancer, liver cancer, colon carcinoma and others.

For the purpose of the current study, scientists chose widely used in Asian and Far Eastern folk medicine: Fomitopsis pinicola, Hericium erinaceus, Inonotus obliquus, and Trametes versicolor. These species of fungi were shown to selectively target certain malignant tumors. The desired effect is achieved thanks to the various bioactive compounds contained in the mushrooms: polyphenols, polysaccharides, glucans, terpenoids, steroids, cerebrosides, and proteins. These substances are not only able to hit different critical targets within cancer cells levels, but in certain cases, can also synergistically boost the chemo. Scientists emphasize that four species of fungi were chosen due to their well-described medicinal properties. Some of them are already actively used for anti-cancer drug manufacturing in certain countries. Undoubtedly, there are many other species of fungi that contain chemical compounds to defeat cancer cells.

"In ancient China, mushrooms were considered as the most effective treatment for the various types of tumors. Contemporary fungotherapy (treatment by means of mushrooms) represents a promising field for scientific research. The natural chemical compounds contained in fungi have a huge therapeutic and particularly the anti-cancer potential that has not been yet fully studied," says Professor Vladimir Katanaev, Dr.Habil, Ph.D.

Corresponding author Alexander Kagansky notes that despite the fact that the interest in mushrooms has been growing exponentially over the past 60 years, about 90 percent of the fungal species have never been analyzed for their antibiotic and antitumor activities.

"Moreover, the significant part of cancer-related research of fungi deals merely with their toxicity to cancer cells and the ability to stop the growth and development of cancer cells. The point is that such properties of the fungi compounds are equally detrimental to the of the body," says Kagansky. Thus, it is necessary to research fungi for the chemical compounds capable of selective, targeted impact on .

Vladimir Katanaev notes the importance of further research the immunomodulatory effect of fungi enriched with polysaccharides. According to him, immunomodulation can be attributed to indirect but effective methods of defeating cancer.

The first generation of natural medical compounds from mushroom extracts wasn't specific and has been tested widely for the therapy of all cancer types without consideration of tumor type properties. Such therapy damaged not only tumor cells but also healthy cells of the body. There were lots of heavy side effects, leading to the death of a patient due to overdose.

Modern approaches to anti-cancer therapy are based on the targeted treatment with minimal or no consequences to the healthy and tissues. For this purpose, the general therapeutic properties of fungal are investigated along with the ways they differ in their action on different tumours.

The scientists hope that the high potential of the fungi for anti-cancer therapy showcased in their article will encourage further research at the junction of oncology and mycology. Currently, the researchers are conducting new experiments to reveal the anti-cancer activities of the mushrooms extracts. This work is aimed at creating the new generation of highly specific low-toxicity drugs, which could be specifically targeted on different tumor types.

Explore further: Novel drug cocktails strengthen targeted cancer therapies while lessening side effects

More information: Artem Blagodatski et al, Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy, Oncotarget (2018). DOI: 10.18632/oncotarget.25660

Related Stories

Novel drug cocktails strengthen targeted cancer therapies while lessening side effects

August 1, 2018
Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

New drug technology may improve treatment options for aggressive types of breast cancer

June 20, 2018
Purdue University researchers have developed a new technology that may change how one of the most aggressive types of breast cancer is treated.

Compounds show potential in fighting brain and breast cancers

July 15, 2015
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumors, opening the way for potential new drugs to be developed.

Scientists develop exciting new option for targeted cancer therapy

December 8, 2016
Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.

Recommended for you

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.